देश: संयुक्त राज्य
भाषा: अंग्रेज़ी
स्रोत: NLM (National Library of Medicine)
SULFADIMETHOXINE (UNII: 30CPC5LDEX) (SULFADIMETHOXINE - UNII:30CPC5LDEX)
Zoetis Inc.
SULFADIMETHOXINE
SULFADIMETHOXINE 250 mg in 5 mL
ORAL
PRESCRIPTION
For the treatment of sulfadimethoxine-sensitive bacterial infections in dogs and cats and bacterial enteritis associated with coccidiosis in dogs. Albon is indicated for the treatment of respiratory, genitourinary tract, enteric, and soft tissue infections in dogs and cats: - tonsillitis - pharyngitis - bronchitis - pneumonia - cystitis - nephritis - metritis - pyometra - pustular dermatitis - anal gland infections - abscesses - wound infections - bacterial enteritis - canine salmonellosis - bacterial enteritis associated with coccidiosis in dogs when caused by streptococci, staphylococci, escherichia, salmonella, klebsiella, proteus or shigella organisms sensitive to sulfadimethoxine. Limitations: Sulfadimethoxine is not effective in viral or rickettsial infections, and as with any antibacterial agent, occasional failures in therapy may occur due to resistant microorganisms. The usual precautions in sulfonamide therapy should be observed.
Albon Oral Suspension is available in 60- and 473-mL bottles; each tsp (5 mL) contains 250 mg sulfadimethoxine in a custard-flavored carrier.
New Animal Drug Application
ALBON- SULFADIMETHOXINE SUSPENSION ZOETIS INC. ---------- ALBON (S ULFADIMETHOXINE) ALBON (_SULFADIMETHOXINE_) ORAL SUSPENSION 5% For the treatment of sulfadimethoxine-sensitive bacterial infections in dogs and cats and bacterial enteritis associated with coccidiosis in dogs. CAUTION Federal law restricts this drug to use by or on the order of a licensed veterinarian. DESCRIPTION Albon is a low-dosage, rapidly absorbed, long-acting sulfonamide, effective for the treatment of a wide range of bacterial infections commonly encountered in dogs and cats. Sulfadimethoxine is a white, almost tasteless and odorless compound. Chemically, it is N -(2,6- dimethoxy-4-pyrimidinyl) sulfanilamide. The structural formula is: CLINICAL PHARMACOLOGY Sulfadimethoxine has been demonstrated clinically or in the laboratory to be effective against a variety of organisms, such as streptococci, klebsiella, proteus, shigella, staphylococci, escherichia, and salmonella. These organisms have been demonstrated in respiratory, genitourinary, enteric, and soft tissue infections of dogs and cats. The systemic sulfonamides which include sulfadimethoxine are bacteriostatic agents. Sulfonamides competitively inhibit bacterial synthesis of folic acid (pteroylglutamic acid) from para-aminobenzoic acid. Mammalian cells are capable of utilizing folic acid in the presence of sulfonamides. The tissue distribution of sulfadimethoxine, as with all sulfonamides, is a function of plasma levels, degree of plasma protein binding, and subsequent passive distribution in the tissues of the lipid-soluble un-ionized form. The relative amounts are determined by both its pKa and by the pH of each tissue. Therefore, levels tend to be higher in less acid tissue and body fluids or those diseased tissues having ® 1 1,2 2 high concentrations of leucocytes. In the dog, sulfadimethoxine is not acetylated as in most other animals, and it is excreted predominantly as the unchanged drug. Sulfadimethoxine has a relatively high solubility at the pH normally occurring in the kid पूरा दस्तावेज़ पढ़ें